Showing results (441-450 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|August 28, 2018
Adjuvant treatment in renal cell carcinomaNazli Dizman, Jacob J Adashek, JoAnn Hsu, et al.Clinical Advances in Hematology & Oncology : H&O|March 14, 2015
New developments in acute lymphoblastic leukemiaDan Douer, Deborah A ThomasClinical Advances in Hematology & Oncology : H&O|April 12, 2021
Neratinib: an option for HER2-positive metastatic breast cancerJoyce A O'Shaughnessy, Ruth O'Regan, Claudine IsaacsClinical Advances in Hematology & Oncology : H&O|April 12, 2021
How to incorporate a chemo-free interval into the management of metastatic colorectal cancerAxel Grothey, Fortunato Ciardiello, John L MarshallClinical Advances in Hematology & Oncology : H&O|April 12, 2021
Refining the management of relapsed or refractory follicular lymphomaJohn M Pagel, John M Burke, Lori A LeslieClinical Advances in Hematology & Oncology : H&O|February 7, 2015
Update on the chemotherapeutic management of endometrial cancerAmy Bregar, Katina Robison, Don S DizonClinical Advances in Hematology & Oncology : H&O|June 4, 2014
Programmed death-1 inhibition in renal cell carcinoma: clinical insights and future directionsSumanta K Pal, Adriana Hu, Mark Chang, et al.Clinical Advances in Hematology & Oncology : H&O|June 4, 2014
How often do hematologists consider celiac disease in iron-deficiency anemia? Results of a national surveyScott Smukalla, Benjamin Lebwohl, J Gregory Mears, et al.Clinical Advances in Hematology & Oncology : H&O|June 4, 2014
The potential role for neoadjuvant therapy in renal cell carcinomaDerek Ho, Hyung L KimClinical Advances in Hematology & Oncology : H&O|June 5, 2014
Clinical phenotypes of castration-resistant prostate cancerTian Zhang, Andrew J ArmstrongPageof 68